🇮🇸 ORF Genetics has secured €5 million to scale production of our MESOkine growth-factor portfolio

We are excited to share with you an important milestone!

ORF Genetics has secured €5M to scale production of our MESOkine growth-factor portfolio—and we’re expanding the round up to €7M by mid-October.

ORF Genetics plans to expand its MESOkine production capacity to unprecedented levels: Fourteenfold by 2027, and by a factor of 10,000 by 2032.

Built for cultivated meat producers, MESOkine delivers reliable, high-quality growth factors as the industry moves from R&D to commercial scale amid rising approvals and new markets.

We produce these proteins in bioengineered barley—a sustainable, safe, and highly cost-effective method—backed by 17 years of growth-factor manufacturing expertise.

Investors: we’re welcoming additional participation to reach €7M. DM us or see contact details in the comments.

Originally published on 10 September by ORF Genetics.

Announcements are published as a service to readers. The sender is responsible for all content.

Announcements for publication can be submitted to [email protected].